← Scroll for more →
Financial Statements — TFPM
Balance Sheet
(in billions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.07 | 0.08 | 0.04 | 0.02 | 0.02 | 0.02 | 0.07 |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Total Current Assets | 0.15 | 0.12 | 0.08 | 0.06 | 0.06 | 0.05 | 0.09 |
| Total Non-current Assets | 1.96 | 1.73 | 1.69 | 1.68 | 1.84 | 1.87 | 1.25 |
| Total Assets | 2.11 | 1.85 | 1.77 | 1.74 | 1.89 | 1.92 | 1.34 |
| Total Current Liabilities | 0.04 | 0.03 | 0.03 | 0.01 | 0.02 | 0.01 | 0.01 |
| Total Non-current Liabilities | 0.03 | 0.01 | 0.01 | 0.03 | 0.07 | 0.07 | 0.01 |
| Total Liabilities* | 0.07 | 0.04 | 0.03 | 0.04 | 0.08 | 0.08 | 0.02 |
| Retained Earnings | 0.16 | 0.05 | (0.02) | (0.07) | 0.05 | 0.07 | 0.06 |
| Total Stockholder Equity | 2.05 | 1.81 | 1.74 | 1.70 | 1.81 | 1.84 | 1.32 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Total Revenue | 94.09 | 63.58 | 52.59 |
| Cost of Revenue* | 31.75 | 24.68 | 25.64 |
| Gross Profit | 62.34 | 38.90 | 26.95 |
| Research & Development | 1.78 | 1.35 | 0.78 |
| Selling, General & Admin | 8.64 | 6.51 | 5.18 |
| Total Operating Expenses* | 7.91 | 149.63 | 6.07 |
| Operating Income | 54.43 | (110.73) | 20.88 |
| Pretax Income | 60.32 | (111.18) | 17.66 |
| Tax Provision | 4.58 | 0.26 | 1.63 |
| Net Income | 55.74 | (111.44) | 16.03 |
| Basic EPS | 0.28 | (0.55) | 0.08 |
| Diluted EPS | 0.28 | (0.55) | 0.08 |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Operating Cash Flow | 76.11 | 49.36 | 40.88 |
| Investing Cash Flow | (0.01) | (6.77) | (24.73) |
| Financing Cash Flow | (13.12) | (50.89) | (21.44) |
← Scroll for more columns →